Funding · Company
Volastra Therapeutics, Inc.
New York, NYBiotech & Pharma
Volastra Therapeutics, Inc. of New York, NY has disclosed $90M across 2 Form D offerings filed with the SEC between Mar 13, 2023 and Sep 23, 2025.
$90M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersNew York, NYIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001968822Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →